Glucose-Lowering and the Risk of Cardiovascular Events With Antidiabetic Therapies: A Systematic Review and Additive-Effects Network Meta-Analysis

AIM: To assess the impact of the HbA1c levels achieved with antidiabetic therapies (ADTs) on the risk of MACE. METHODS: A systematic search was performed in PubMed, Cochrane, and ClinicalTrials. gov for RCTs published up to March 2022 reporting the occurrence of MACE and all-cause mortality in indiv...

Descripción completa

Detalles Bibliográficos
Autores principales: de Carvalho, Luiz Sergio Fernandes, Nogueira, Ana Claudia Cavalcante, Bonilha, Isabella, Luchiari, Beatriz, Benchimol, Alexander, Couri, Carlos Eduardo Barra, Borges, Jairo Lins, Barreto, Joaquim, Sposito, Andrei C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098935/
https://www.ncbi.nlm.nih.gov/pubmed/35571207
http://dx.doi.org/10.3389/fcvm.2022.876795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098935/
https://www.ncbi.nlm.nih.gov/pubmed/35571207
http://dx.doi.org/10.3389/fcvm.2022.876795

Ejemplares similares